A-NEURON ELECTRONIC CORP.
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
A-NEURON ELECTRONIC CORP. Navigation-Assisted Diagnostic Software. An auxiliary diagnostic tool designed to assist in interpreting recurring specific waveform characteristics, it is used to help physicians review the onset times of epileptic seizures in EEG data and provide visual representations. It does not provide any final diagnosis for any disease or decision-making outcomes for disease treatment.
The content above was translated by Ai
Founded Year
2016
Unified Business No.
45115082
Status
Active
Number of Employees
0
Total Paid-in
Capital
444,650,000 (NT$)
Location of Company
Taiwan
, Hsinchu County
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
"A-NEURON ELECTRONIC CORP." was established in June 2016, located adjacent to the Taiwan Hsinchu High-Speed Rail Station and the Zhubei Biomedical Park. The company was co-founded by Dr. Hsin-Chin Jiang, through a technology transfer of the biomedical chip technology from the research team of Professor Chung-Yu Wu and Professor Ming-Dou Ker at National Chiao Tung University, together with the R&D team of the Biomedical Electronics Translational Research Center at National Chiao Tung University. In August 2020, Dr. Chung-Yu Wu personally took the lead (serving as Chairman and Chief Technology Officer), leading the research team to continuously conduct research and development in biomedical chip technology.
The company primarily targets neurological diseases that cannot be treated with medication (refractory), providing lifelong solutions applied to fields such as epilepsy, Parkinson's disease, macular degeneration, and retinitis pigmentosa, as well as providing auxiliary systems for related diagnosis, monitoring, and treatment.
The company primarily targets neurological diseases that cannot be treated with medication (refractory), providing lifelong solutions applied to fields such as epilepsy, Parkinson's disease, macular degeneration, and retinitis pigmentosa, as well as providing auxiliary systems for related diagnosis, monitoring, and treatment.
The content above was translated by Ai
